Market Overview:
The global bradykinin B1 receptor market is expected to grow at a CAGR of xx% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing prevalence of chronic diseases, rising geriatric population, and growing demand for novel therapeutics. The type segment of the global bradykinin B1 receptor market is expected to grow at a CAGR of xx% during the forecast period from 2018 to 2030. The application segment of the global bradykinin B1 receptor market is expected to grow at a CAGR of xx% during the forecast period from 2018 to 2030. North America dominates the global bradykinin B1 receptor market and is projected to maintain its dominance throughout the forecast period.
Product Definition:
BI-113823:
BI-113823 is a human growth factor receptor that binds with high affinity to the extracellular domain of transforming growth factor (TGF)-?1. It was discovered in a series of bio-assays screening methods for the identification of small molecule inhibitors for kinases from the Tyrosine Kinase Receptor (Trk) family.
Others:
Others is a group of immunoglobulin G antibodies, which are produced in response to an antigen other than the ones for which the individual is normally equipped. In other words, they are an antibody that occurs in individuals who have not been exposed to the particular antigen. They can be used as markers for identifying and tracking immune responses induced by foreign antigens.
Application Insights:
The application segment is sub-divided into clinic, hospital and household. The clinic segment held the largest share of over 70% in 2017. This is due to the rising number of patients suffering from gastrointestinal disorders requiring a diagnosis by an allergist or immunologist. In such cases, allergic reactions to medicines are not uncommonly reported along with symptoms like diarrhea and abdominal cramps. Thus, people visiting doctors for chronic diseases often require a diagnosis by an allergist which boosts up the usage of BRB1 receptor antagonists in clinics for treating these diseases without any positive results being obtained so far after trying several medicines/injections etc.
Regional Analysis:
Europe accounted for the largest share of global revenue in 2017. The presence of key manufacturers and well-developed healthcare infrastructure are some factors responsible for its large share. Moreover, increasing prevalence of chronic diseases such as rheumatoid arthritis, osteoarthritis, and other musculoskeletal disorders is expected to drive the regional market over the forecast period.
The Asia Pacific market is anticipated to witness significant growth during the forecast period owing to rising disposable income coupled with growing awareness about early diagnosis & treatment options for various chronic diseases in emerging countries such as China and India. Furthermore, government initiatives aimed at improving healthcare facilities across developing nations are likely to contribute toward industry growth in this region.
Growth Factors:
- Increasing prevalence of chronic diseases such as cancer, cardiovascular diseases, and diabetes is expected to drive the growth of the bradykinin B1 receptor market.
- Rising geriatric population is also anticipated to fuel the demand for bradykinin B1 receptor drugs in the near future.
- Growing awareness about available treatment options for various chronic diseases is projected to boost the demand for bradykinin B1 receptor drugs in coming years.
- Technological advancements in drug discovery and development are likely to create new opportunities for players operating in this market over the forecast period. 5) increasing investment by pharmaceutical companies in research and development activities aimed at developing novel therapies for treating chronic diseases will propel growth of this market during forecast period
Scope Of The Report
Report Attributes
Report Details
Report Title
Bradykinin B1 Receptor Market Research Report
By Type
BI-113823, Others
By Application
Clinic, Hospital, Household
By Companies
Axxam SpA, Boehringer Ingelheim GmbH, Dompe Farmaceutici S.p.A., Grunenthal GmbH
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
166
Number of Tables & Figures
117
Customization Available
Yes, the report can be customized as per your need.
Global Bradykinin B1 Receptor Market Report Segments:
The global Bradykinin B1 Receptor market is segmented on the basis of:
Types
BI-113823, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Clinic, Hospital, Household
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Axxam SpA
- Boehringer Ingelheim GmbH
- Dompe Farmaceutici S.p.A.
- Grunenthal GmbH
Highlights of The Bradykinin B1 Receptor Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- BI-113823
- Others
- By Application:
- Clinic
- Hospital
- Household
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Bradykinin B1 Receptor Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Bradykinin B1 receptor is a protein that binds bradykinin, a peptide hormone that stimulates nerve cells. Bradykinin B1 receptor is found in the smooth muscle of the intestines and other organs.
Some of the major players in the bradykinin b1 receptor market are Axxam SpA, Boehringer Ingelheim GmbH, Dompe Farmaceutici S.p.A., Grunenthal GmbH.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Bradykinin B1 Receptor Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Bradykinin B1 Receptor Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Bradykinin B1 Receptor Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Bradykinin B1 Receptor Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Bradykinin B1 Receptor Market Size & Forecast, 2020-2028
4.5.1 Bradykinin B1 Receptor Market Size and Y-o-Y Growth
4.5.2 Bradykinin B1 Receptor Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 BI-113823
5.2.2 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Clinic
6.2.2 Hospital
6.2.3 Household
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Bradykinin B1 Receptor Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Bradykinin B1 Receptor Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 BI-113823
9.6.2 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Clinic
9.10.2 Hospital
9.10.3 Household
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 BI-113823
10.6.2 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Clinic
10.10.2 Hospital
10.10.3 Household
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 BI-113823
11.6.2 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Clinic
11.10.2 Hospital
11.10.3 Household
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 BI-113823
12.6.2 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Clinic
12.10.2 Hospital
12.10.3 Household
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 BI-113823
13.6.2 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Clinic
13.10.2 Hospital
13.10.3 Household
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Bradykinin B1 Receptor Market: Competitive Dashboard
14.2 Global Bradykinin B1 Receptor Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Axxam SpA
14.3.2 Boehringer Ingelheim GmbH
14.3.3 Dompe Farmaceutici S.p.A.
14.3.4 Grunenthal GmbH
